Czechia, June 19 -- Czechia based AbbVie s.r.o. has secured contract from Fakultni nemocnice Brno for Pharmaceutical products Supplies of medicinal preparations with the active substance MIRVETUXIMAB SORAVTANSIN . The value of the contract is worth 2708856000 CZK .
Published by HT Digital Content Services with permission from Pivotal Sources....